Upregulation of COX-2 and PGE₂ Induced by TNF-α Mediated Through TNFR1/MitoROS/PKCα/P38 MAPK, JNK1/2/FoxO1 Cascade in Human Cardiac Fibroblasts

References

• Humeres C, Frangogiannis NG. Fibroblasts in the infarcted, remodeling, and failing heart. JACC Basic Transl Sci. 2019;4(3):449–467. doi:10.1016/j.jacbts.2019.02.006
   PubMedGoogle Scholar
• Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol. 2010;225(3):631–637. doi:10.1002/jcp.22322
   PubMed Web of Science ®Google Scholar
• Bartekova M, Radosinska J, Jelemensky M, Dhalla NS. Role of cytokines and inflammation in heart function during health and disease. Heart Fail Rev. 2018;23(5):733–758. doi:10.1007/s10741-018-9716-x
   PubMed Web of Science ®Google Scholar
• Schumacher SM, Naga Prasad SV. Tumor necrosis factor-α in heart failure: an updated review. Curr Cardiol Rep. 2018;20(11):117. doi:10.1007/s11886-018-1067-7
   PubMed Web of Science ®Google Scholar
• Sun M, Chen M, Dawood F, et al. Tumor necrosis factor-α mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation. 2007;115(11):1398–1407. doi:10.1161/CIRCULATIONAHA.106.643585
   PubMed Web of Science ®Google Scholar
• Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323(4):236–241. doi:10.1056/nejm199007263230405
   PubMed Web of Science ®Google Scholar
• Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93(4):704–711. doi:10.1161/01.cir.93.4.704
   PubMed Web of Science ®Google Scholar
• Lin CC, Hsiao LD, Chien CS, Lee CW, Hsieh JT, Yang CM. Tumor necrosis factor-α-induced cyclooxygenase-2 expression in human tracheal smooth muscle cells: involvement of p42/p44 and p38 mitogen-activated protein kinases and nuclear factor-κB. Cell Signal. 2004;16(5):597–607. doi:10.1016/j.cellsig.2003.10.002
   PubMed Web of Science ®Google Scholar
• Nakao S, Ogtata Y, Shimizu E, Yamazaki M, Furuyama S, Sugiya H. Tumor necrosis factor alpha (TNF-α)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFκB in human gingival fibroblasts. Mol Cell Biochem. 2002;238(1/2):11–18. doi:10.1023/a:1019927616000
   PubMed Web of Science ®Google Scholar
• Chen CC, Sun YT, Chen JJ. TNF-α-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-γ2, protein kinase C-α, tyrosine kinase, NF-κB-inducing kinase, and I-κB kinase 1/2 pathway. J Immunol. 2000;165(5):2719–2728. doi:10.4049/jimmunol.165.5.2719
   PubMed Web of Science ®Google Scholar
• Ma Y, Yue Z, Zhang B, et al. Calcium signal pathway is involved in prostaglandin E2 induced cardiac fibrosis in cardiac fibroblasts. J Pharm Pharm Sci. 2018;21(1):326–339. doi:10.18433/jpps29322
   PubMedGoogle Scholar
• Harding P, LaPointe MC. Prostaglandin E2 increases cardiac fibroblast proliferation and increases cyclin D expression via EP1 receptor. Prostaglandins Leukot Essent Fatty Acids. 2011;84(5–6):147–152. doi:10.1016/j.plefa.2011.01.003
   PubMed Web of Science ®Google Scholar
• Peoples JN, Saraf A, Ghazal N, Pham TT, Kwong JQ. Mitochondrial dysfunction and oxidative stress in heart disease. Exp Mol Med. 2019;51(12):1–13. doi:10.1038/s12276-019-0355-7
   PubMed Web of Science ®Google Scholar
• Ye Y, Li J, Yuan Z. Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS One. 2013;8(2):e56803. doi:10.1371/journal.pone.0056803
   PubMed Web of Science ®Google Scholar
• Escobales N, Nunez RE, Jang S, et al. Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged rats. J Mol Cell Cardiol. 2014;77:136–146. doi:10.1016/j.yjmcc.2014.10.009
   PubMed Web of Science ®Google Scholar
• Onodera Y, Teramura T, Takehara T, Shigi K, Fukuda K. Reactive oxygen species induce Cox-2 expression via TAK1 activation in synovial fibroblast cells. FEBS Open Bio. 2015;5:492–501. doi:10.1016/j.fob.2015.06.001
   PubMed Web of Science ®Google Scholar
• Zhao Y, Usatyuk PV, Gorshkova IA, et al. Regulation of COX-2 expression and IL-6 release by particulate matter in airway epithelial cells. Am J Respir Cell Mol Biol. 2009;40(1):19–30. doi:10.1165/rcmb.2008-0105OC
   PubMed Web of Science ®Google Scholar
• Inagaki K, Churchill E, Mochly-Rosen D. Epsilon protein kinase C as a potential therapeutic target for the ischemic heart. Cardiovasc Res. 2006;70(2):222–230. doi:10.1016/j.cardiores.2006.02.015
   PubMed Web of Science ®Google Scholar
• Liu Q, Molkentin JD. Protein kinase Cα as a heart failure therapeutic target. J Mol Cell Cardiol. 2011;51(4):474–478. doi:10.1016/j.yjmcc.2010.10.004
   PubMed Web of Science ®Google Scholar
• Huang WC, Chen JJ, Inoue H, Chen CC. Tyrosine phosphorylation of I-κB kinase α/β by protein kinase C-dependent c-Src activation is involved in TNF-α-induced cyclooxygenase-2 expression. J Immunol. 2003;170(9):4767–4775. doi:10.4049/jimmunol.170.9.4767
   PubMed Web of Science ®Google Scholar
• Tseng HC, Lin CC, Hsiao LD, Yang CM. Lysophosphatidylcholine-induced mitochondrial fission contributes to collagen production in human cardiac fibroblasts. J Lipid Res. 2019;60(9):1573–1589. doi:10.1194/jlr.RA119000141
   PubMed Web of Science ®Google Scholar
• Kitanaka T, Nakano R, Kitanaka N, et al. JNK activation is essential for activation of MEK/ERK signaling in IL-1β-induced COX-2 expression in synovial fibroblasts. Sci Rep. 2017;7(1):39914. doi:10.1038/srep39914
   PubMedGoogle Scholar
• Wu G, Luo J, Rana JS, Laham R, Sellke FW, Li J. Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc Res. 2006;69(2):512–519. doi:10.1016/j.cardiores.2005.09.019
   PubMed Web of Science ®Google Scholar
• Hobbs SS, Goettel JA, Liang D, et al. TNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2011;301(2):G220–9. doi:10.1152/ajpgi.00383.2010
   PubMed Web of Science ®Google Scholar
• Saini S, Liu T, Yoo J. TNF-α stimulates colonic myofibroblast migration via COX-2 and Hsp27. J Surg Res. 2016;204(1):145–152. doi:10.1016/j.jss.2016.04.034
   PubMed Web of Science ®Google Scholar
• Kim JJ, Lee SB, Park JK. TNF-α-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-X(L). Cell Death Differ. 2010;17(9):1420–1434. doi:10.1038/cdd.2010.19
   PubMed Web of Science ®Google Scholar
• Suematsu N, Tsutsui H, Wen J, et al. Oxidative stress mediates tumor necrosis factor-α-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation. 2003;107(10):1418–1423. doi:10.1161/01.cir.0000055318.09997.1f
   PubMed Web of Science ®Google Scholar
• Sanchez-Bautista S, Nicolas FE. Recent patents concerning modulators of protein kinase C. Recent Pat DNA Gene Seq. 2013;7(1):74–81. doi:10.2174/1872215611307010011
   PubMedGoogle Scholar
• Kassem KM, Clevenger MH, Szandzik DL, Peterson E, Harding P. PGE2 reduces MMP-14 and increases plasminogen activator inhibitor-1 in cardiac fibroblasts. Prostaglandins Other Lipid Mediat. 2014;113–115:62–68. doi:10.1016/j.prostaglandins.2014.09.002
   PubMed Web of Science ®Google Scholar
• Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3(9):745–756. doi:10.1038/nri1184
   PubMed Web of Science ®Google Scholar
• Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest. 1995;96(2):1042–1052. doi:10.1172/jci118090
   PubMed Web of Science ®Google Scholar
• Li YY, Feng YQ, Kadokami T, et al. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor α can be modulated by anti-tumor necrosis factor α therapy. Proc Natl Acad Sci U S A. 2000;97(23):12746–12751. doi:10.1073/pnas.97.23.12746
   PubMed Web of Science ®Google Scholar
• Chen X, Subleski JJ, Kopf H, Howard OZ, Männel DN, Oppenheim JJ. Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+ CD25+ FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells. J Immunol. 2008;180(10):6467–6471. doi:10.4049/jimmunol.180.10.6467
   PubMed Web of Science ®Google Scholar
• Wen X, Chen X, Liang X, et al. The small molecule NSM00191 specifically represses the TNF-α/NF-small ka, CyrillicB axis in foot and ankle rheumatoid arthritis. Int J Biol Sci. 2018;14(12):1732–1744. doi:10.7150/ijbs.24232
   PubMed Web of Science ®Google Scholar
• Aoki T, Fukuda M, Nishimura M, Nozaki K, Narumiya S. Critical role of TNF-α-TNFR1 signaling in intracranial aneurysm formation. Acta Neuropathol Commun. 2014;2:34. doi:10.1186/2051-5960-2-34
   PubMed Web of Science ®Google Scholar
• Grell M, Wajant H, Zimmermann G, Scheurich P. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proce National Acad Sci. 1998;95(2):570–575. doi:10.1073/pnas.95.2.570
   PubMed Web of Science ®Google Scholar
• Rolski F, Błyszczuk P. Complexity of TNF-α signaling in heart disease. J Clin Med. 2020;9. doi:10.3390/jcm9103267
   PubMed Web of Science ®Google Scholar
• Hermida N, Michel L, Esfahani H, et al. Cardiac myocyte β3-adrenergic receptors prevent myocardial fibrosis by modulating oxidant stress-dependent paracrine signaling. Eur Heart J. 2018;39(10):888–898. doi:10.1093/eurheartj/ehx366
   PubMed Web of Science ®Google Scholar
• Li X, Zhang W, Cao Q, et al. Mitochondrial dysfunction in fibrotic diseases. Cell Death Discovery. 2020;6(1):80. doi:10.1038/s41420-020-00316-9
   PubMed Web of Science ®Google Scholar
• Dai D-F, Hsieh EJ, Liu Y, et al. Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress. Cardiovasc Res. 2012;93(1):79–88. doi:10.1093/cvr/cvr274
   PubMed Web of Science ®Google Scholar
• Ide T, Tsutsui H, Hayashidani S, et al. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res. 2001;88(5):529–535. doi:10.1161/01.RES.88.5.529
   PubMed Web of Science ®Google Scholar
• Bhatti JS, Bhatti GK, Reddy PH. Mitochondrial dysfunction and oxidative stress in metabolic disorders—A step towards mitochondria based therapeutic strategies. Biochimica et Biophysica Acta. 2017;1863(5):1066–1077. doi:10.1016/j.bbadis.2016.11.010
   PubMed Web of Science ®Google Scholar
• Jiménez-González S, Marín-Royo G, Jurado-López R, et al. The Crosstalk between cardiac lipotoxicity and mitochondrial oxidative stress in the cardiac alterations in diet-induced obesity in rats. Cells. 2020;9(2):451. doi:10.3390/cells9020451
   PubMed Web of Science ®Google Scholar
• Sverdlov AL, Elezaby A, Qin F, et al. Mitochondrial reactive oxygen species mediate cardiac structural, functional, and mitochondrial consequences of diet‐induced metabolic heart disease. J Am Heart Assoc. 2016;5(1):e002555. doi:10.1161/JAHA.115.002555
   PubMed Web of Science ®Google Scholar
• Blaser H, Dostert C, Mak TW, Brenner D. TNF and ROS crosstalk in inflammation. Trends Cell Biol. 2016;26(4):249–261. doi:10.1016/j.tcb.2015.12.002
   PubMed Web of Science ®Google Scholar
• Ferreira JCB, Brum PC, Mochly-Rosen D. βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure. J Mol Cell Cardiol. 2011;51(4):479–484. doi:10.1016/j.yjmcc.2010.10.020
   PubMed Web of Science ®Google Scholar
• Singh RM, Cummings E, Pantos C, Singh J. Protein kinase C and cardiac dysfunction: a review. Heart Fail Rev. 2017;22(6):843–859. doi:10.1007/s10741-017-9634-3
   PubMed Web of Science ®Google Scholar
• Song X, Qian X, Shen M, et al. Protein kinase C promotes cardiac fibrosis and heart failure by modulating galectin-3 expression. Biochim Biophys Acta. 2015;1853(2):513–521. doi:10.1016/j.bbamcr.2014.12.001
   PubMed Web of Science ®Google Scholar
• Koide Y, Tamura K, Suzuki A, et al. Differential induction of protein kinase C isoforms at the cardiac hypertrophy stage and congestive heart failure stage in Dahl salt-sensitive rats. Hypertension Res. 2003;26(5):421–426. doi:10.1291/hypres.26.421
   PubMed Web of Science ®Google Scholar
• Marrocco V, Bogomolovas J, Ehler E, et al. PKC and PKN in heart disease. J Mol Cell Cardiol. 2019;128:212–226. doi:10.1016/j.yjmcc.2019.01.029
   PubMed Web of Science ®Google Scholar
• Liu Q, Molkentin JD. Protein kinase Cα as a heart failure therapeutic target. J Mol Cell Cardiol. 2011;51(4):474–478. doi:10.1016/j.yjmcc.2010.10.004
   PubMed Web of Science ®Google Scholar
• Giroux M, Descoteaux A. Cyclooxygenase-2 expression in macrophages: modulation by protein kinase C-α. J Immunol. 2000;165(7):3985–3991. doi:10.4049/jimmunol.165.7.3985
   PubMed Web of Science ®Google Scholar
• Nakashima S. Protein kinase C alpha (PKC α): regulation and biological function. J Biochem. 2002;132(5):669–675. doi:10.1093/oxfordjournals.jbchem.a003272
   PubMed Web of Science ®Google Scholar
• Yu W, Chen C, Cheng J. The role and molecular mechanism of FoxO1 in mediating cardiac hypertrophy. ESC Heart Failure. 2020;7(6):3497–3504. doi:10.1002/ehf2.13065
   PubMed Web of Science ®Google Scholar
• Hsu CK, Lin CC, Hsiao LD, Yang CM. Mevastatin ameliorates sphingosine 1-phosphate-induced COX-2/PGE2-dependent cell migration via FoxO1 and CREB phosphorylation and translocation. Br J Pharmacol. 2015;172(22):5360–5376. doi:10.1111/bph.13326
   PubMed Web of Science ®Google Scholar
• Tseng HC, Lin CC, Wang CY, Yang CC, Hsiao LD, Yang CM. Lysophosphatidylcholine induces cyclooxygenase-2-dependent IL-6 expression in human cardiac fibroblasts. Cell Mol Life Sci. 2018;75(24):4599–4617. doi:10.1007/s00018-018-2916-7
   PubMed Web of Science ®Google Scholar
• Su D, Coudriet GM, Hyun Kim D, et al. FoxO1 links insulin resistance to proinflammatory cytokine IL-1β production in macrophages. Diabetes. 2009;58(11):2624–2633. doi:10.2337/db09-0232
   PubMed Web of Science ®Google Scholar
• Alikhani M, Alikhani Z, Graves DT. FOXO1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor-induced fibroblast apoptosis. J Biol Chem. 2005;280(13):12096–12102. doi:10.1074/jbc.M412171200
   PubMed Web of Science ®Google Scholar